Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.63 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.63 |
| ▸ | KMO | O15229 | 3/20 | 0.43 |
| ▸ | KYNU | Q16719 | 3/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.40 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.40 |
| ▸ | ALPI | P09923 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | XIAP | P98170 | 1/20 | 0.40 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30852376 | 0.83 | KMO (0.51) | KDM4EHIF1ATDP1KMOKYNU | |
| SCHEMBL30852338 | 0.83 | KMO (0.51) | KDM4EHIF1ATDP1KMOKYNU | |
| SCHEMBL31520067 | 0.83 | KMO (0.51) | KDM4EHIF1ATDP1KMOKYNU | |
| SCHEMBL9039079 | 0.83 | KDM4E (0.50) | KDM4EHIF1ATDP1KMOKYNU | |
| SCHEMBL1305231 | 0.83 | KMO (0.51) | KDM4EHIF1ATDP1KMOKYNU | |
| SCHEMBL24591475 | 0.79 | CA12 (0.47) | KDM4EHIF1ATDP1KMOKYNU | |
| SCHEMBL9340027 | 0.79 | KDM4E (0.47) | KDM4EHIF1ATDP1KMOKYNU | |
| SCHEMBL1332674 | 0.79 | CA12 (0.47) | KDM4EHIF1ATDP1KMOKYNU | |
| Kynurenine SCHEMBL4577458 | 0.78 | KDM4E (0.68) | KDM4EHIF1ATDP1KMOKYNU | |
| SCHEMBL180582 | 0.77 | KDM4E (1.00) | KDM4EHIF1ATDP1KMOKYNU |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119285544-A | Method for separating and preparing natural 6-hydroxykynurenic acid from ginkgo leaves | 浙江理工大学绍兴生物医药研究院有限公司 | 2025-01-10 | — | — | CN | claimed |
| US-12076316-B2 | Levorphanol prodrugs and processes for making and using them | ZEVRA THERAPEUTICS INC. | 2024-09-03 | — | — | US | claimed |
| WO-2023246355-A1 | GINKGO LEAF ORGANIC ACID EXTRACT, METHOD FOR PREARING SAME AND USE THEREOF | 浙江康恩贝制药股份有限公司 | 2023-12-28 | — | — | WO | claimed |
| CN-115006435-B | Ginkgo leaf organic acid extract and preparation method and application thereof | 浙江康恩贝制药股份有限公司 | 2023-11-28 | — | — | CN | claimed |
| CN-115894515-A | Method for integrated extraction, enrichment, separation and purification of effective components of ginkgo leaves in full industrial chain | 李玉山 | 2023-04-04 | — | — | CN | claimed |
| CN-114366761-B | Preparation method of ginkgo leaf extract rich in organic acid | 江苏得乐康生物科技有限公司 | 2022-11-01 | — | — | CN | claimed |
| CN-115006435-A | Ginkgo leaf organic acid extract and preparation method and application thereof | 浙江康恩贝制药股份有限公司 | 2022-09-06 | — | — | CN | claimed |
| CN-114366761-A | Preparation method of ginkgo leaf extract rich in organic acid | 江苏得乐康生物科技有限公司 | 2022-04-19 | — | — | CN | claimed |
| US-20220096463-A1 | LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM | ALTER DOMUS (US) LLC | 2022-03-31 | — | — | US | claimed |
| US-11234975-B2 | Levorphanol prodrugs and processes for making and using them | KEMPHARM, INC. (US) | 2022-02-01 | — | — | US | claimed |
| US-8795693-B2 | Compositions with modulating agents | FOAMIX LTD. (IL) | 2014-08-05 | — | — | US | claimed |
| EP-2736510-A2 | METHYLPHENIDATE-PRODRUGS, PROCESSES OF MAKING AND USING THE SAME | Kempharm, Inc. (US) | 2014-06-04 | — | — | EP | claimed |
| US-20130150395-A1 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF | KEMPHARM, INC. (US) | 2013-06-13 | — | — | US | claimed |
| WO-2013063204-A1 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF | KEMPHARM, INC. (US) | 2013-05-02 | — | — | WO | claimed |
| WO-2013016668-A2 | METHYLPHENIDATE-PRODRUGS, PROCESSES OF MAKING AND USING THE SAME | KEMPHARM INC. (US) | 2013-01-31 | — | — | WO | claimed |
| CN-102133243-A | Folium ginkgo extract containing 6-hydroxykynurenic acid | SHANGHAI NOVANAT BIORESOURCES CO LTD | 2011-07-27 | — | — | CN | claimed |
| EP-2097065-A2 | FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS | Foamix Ltd. (IL) | 2009-09-09 | — | — | EP | claimed |
| WO-2008152444-A2 | FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS | FOAMIX LTD. (US) | 2008-12-18 | — | — | WO | claimed |
| US-20080206159-A1 | Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions | FOAMIX LTD. (IL) | 2008-08-28 | — | — | US | claimed |
| CN-1965870-A | Pharmaceutical composition containing ligustrazine and effective component of ginkgo leaf and formulation thereof | BEIJING TIANXINYUAN MEDICINE T (CN) | 2007-05-23 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080206159-A1 | Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions | CUTA, SLTM, SMO | KDM4E 4432/4885HIF1A 2481/4885TDP1 4447/4885 |
| US-12076316-B2 | Levorphanol prodrugs and processes for making and using them | OPRM1, OPRL1, OPRK1 | KDM4E 2657/4885HIF1A 2461/4885TDP1 1241/4885 |
| US-11234975-B2 | Levorphanol prodrugs and processes for making and using them | OPRM1, OPRL1, OPRK1 | KDM4E 2657/4885HIF1A 2461/4885TDP1 1241/4885 |
| US-20130150395-A1 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF | OPRM1, OPRK1, CYP2D6 | KDM4E 3324/4885HIF1A 415/4885TDP1 1353/4885 |
| US-20220096463-A1 | LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM | OPRM1, OPRL1, OPRK1 | KDM4E 2657/4885HIF1A 2461/4885TDP1 1241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.